GlassScriptPhysician profile
Matthew Hrin
NPI 1740939339
$2,087.59
in general payments reported to CMS, 2019-2025
7 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $55.22 · 2023: $89.85 · 2024: $285 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,530 · Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,530.00 |
| Food and Beverage | $502.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $1,685.02 | 2024-2025 | Opzelura |
| Galderma Laboratories, L.P. | $93.81 | 2024 | |
| Abbvie INC. | $89.85 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.49 | 2024 | Spevigo |
| Dermavant Sciences, INC. | $76.20 | 2024 | Vtama |
| Pfizer INC. | $39.22 | 2022 | |
| Novo Nordisk INC | $16.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.